Clinical Study of Radiotherapy Combined With Camrelizumab and Apatinib in the Treatment of Liver Cancer Patients .
Clinical trial NCT06632522 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06632522
- Sponsor
- Beijing Tsinghua Chang Gung Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-20
- Primary completion
- 2025-11-30
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.